• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Mitosol Logo

Mitosol®

Mitosol Has It All

  • HOME
  • CONTACT
  • ORDER
  • RESOURCES
    • Mitosol Resource Center
    • The Mitosol Kit
    • What is Mitosol?
    • Getting Started with Mitosol
  • ABOUT US

Reach out anytime and we’ll happily answer your questions.

Request Info about Mitosol

Request Info

Use the form below to request information, or get help with Mobius products.

Request Info
Contact Us

Customer Support

Call our customer support department.

877-EYE-MITO
314-615-6930
Contact a Mitosol Sales Rep

Sales Inquiry

Contact a member of our Sales team directly for immediate assistance.

Contact Sales Rep
Contact Medical Services

Medical Affairs

Contact one of our healthcare professionals for detailed clinical expertise.

Medical Affairs


Request Information


Contact Your Local Sales Rep

WA, OR, ID, MT, AK

Randy Loren
360-904-5756

Email

Northern-CA, Northern-NV (Reno)

Carol Diamantine
510-918-8875

Email

Southern-CA

Nick Kostechko
714-328-5115

Email

UT

Jason Smith
801-706-7439

Email

GA, Eastern-TN

Unassigned
877-393-6486

Email

CO, WY

Unassigned
877-393-6486

Email

TX, OK, AR, Western Louisiana border region with TX

Tom Gregory
214-697-0137

Email

KS, MO, NE, IA, Southern-IL

Paul Salmon
314-341-3744

Email

VA, Southern-WV

Jerry St. Pierre
540-520-2423

Email

LA except western border, I-10 corridor of Southern MS & AL, FL Panhandle

Jackie Martello
504-289-0481

Email

AZ, NM

Shawn Bidot
602-513-6024

Email

AL except Mobile (zip codes 36600 – 36699), MS except Gulfport & Biloxi (zip codes 39500 – 39599)

Unassigned
877-393-6486

Email

ND, SD, MN, Northern-WI

Rick Bancroft
612-867-3671

Email

MI,Northern-IL, Northern-IN, Southern–WI

Chuck Julius
630-886-4734

Email

OH, KY, Central & Western-TN, Central & Southern-IN, Indianapolis

David Patterson
502-905-3886

Email

NC, SC

Stan Durham
803-920-3777

Email

Florida except the Panhandle

Andy Rivero
772-559-5272

Email

MD, DC, NJ, PA, DE, NY, CT, RI, MA, VT, NH, ME, Northern-WV

Jan Lupnacca
314-605-4995

Email

Hawaii & Guam

Unassigned
877-393-6486

Email

NV except Reno

Patrick King
630-696-5787

Email


Contact Medical Affairs

Medical Director

Lou Schwarz, MD
314-779-8132

Email

Director of Clinical Applications

Linda Kalata, RN, BSN, CNOR
312-213-7546

Email

WMI-018 Rev 05/2021

Footer

INDICATION

Mitosol® (mitomycin for solution) 0.2 mg/vial Kit for Ophthalmic Use is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.

Dosage & Administration

Mitosol® is intended for topical application to the surgical site of glaucoma filtration surgery and must be reconstituted prior to application. Sponges provided within the Mitosol® kit should be fully saturated with the entire reconstituted contents in a manner prescribed in the Instructions For Use. The sponge(s) should be applied to the treatment area for two minutes. Reconstituted Mitosol® should be used within one hour of reconstitution.

US Patents #7,806,265, #8,186,511, #D685,962, #D685,963, #9,205,075, #9,539,241 and #9,649,428; other international patents issued and pending.

Product Information

Please click here for full Product Information for Mitosol®

IMPORTANT SAFETY INFORMATION
Contraindications

Mitosol® is contraindicated in patients that have demonstrated a hypersensitivity to mitomycin in the past.

Warnings & Precautions

Cell Death: Mitomycin is cytotoxic. Use of mitomycin in concentrations higher than 0.2 mg/mL or use for longer than 2 minutes may lead to unintended corneal and/or sclera damage including thinning or perforation. Direct contact with the corneal endothelium will result in cell death. Hypotony: The use of mitomycin has been associated with an increased instance of post-operative hypotony. Cataract Development: Use in phakic patients has been correlated to a higher instance of lenticular change and cataract formation. Embryo-Fetal Toxicity: Can cause fetal harm. Advise of potential risk to a fetus. Verify pregnancy status in females of reproductive potential prior to use.

Adverse Events & Reactions

The most frequent adverse reactions to Mitosol® occur locally and include hypotony, hypotony maculopathy, blebitis, endophthalmitis, vascular reactions, corneal reactions, and cataract. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch, or call 1-800-FDA-1088.

This site is intended only for US residents.
Use of website is governed by the Terms of Use and Privacy Policy
Corporate Responsibility